Regeneron Pharmaceuticals
Trading under the ticker REGN, Regeneron Pharmaceuticals is a healthcare publicly traded company based in New York. The company was founded in 1988 and is headquartered in New York. It operates in the healthcare sector. Its most recent annual filing reported revenue of about 14 billion dollars for fiscal 2025, per SEC 10-K filed 2026-02-04. These figures are factual reference only and are not investment advice. Facts on this page are drawn from public sources including SEC EDGAR, Wikidata, and the company's own disclosures, each linked below.
Company facts
| Headquarters | Eastview, New York |
|---|---|
| Founded | 1988 |
| Type | public |
| Ticker | REGN |
| Website | www.regeneron.com/ |
Financials
$14B revenue for fiscal 2025 ($14,342,900,000).
| Fiscal year | Revenue | Source |
|---|---|---|
| 2025 | $14B | SEC 10-K filed 2026-02-04 |
| 2024 | $14B | SEC 10-K filed 2026-02-04 |
| 2023 | $13B | SEC 10-K filed 2026-02-04 |
| 2022 | $12B | SEC 10-K filed 2025-02-05 |
| 2021 | $16B | SEC 10-K filed 2024-02-05 |
Jobs at Regeneron Pharmaceuticals
Search current openings at Regeneron Pharmaceuticals →
This is an affiliate link to a third-party job board. See our disclosure.
Frequently asked questions
Where is Regeneron Pharmaceuticals located?
Regeneron Pharmaceuticals is based in Eastview, New York.
When was Regeneron Pharmaceuticals founded?
Regeneron Pharmaceuticals was founded in 1988.
Is Regeneron Pharmaceuticals publicly traded?
Yes. Regeneron Pharmaceuticals is a public company trading under the ticker REGN.
What industry is Regeneron Pharmaceuticals in?
Regeneron Pharmaceuticals operates in healthcare.
Related companies
Sources
- Wikipedia (facts only; descriptions on this page are original)
- Wikidata Q7308054 (CC0)
- SEC EDGAR filings (public domain), CIK 0000872589